Hussmann Bjoern, Schoeneberg Carsten, Jungbluth Pascal, Heuer Matthias, Lefering Rolf, Maek Teresa, Hildebrand Frank, Lendemans Sven, Pape Hans-Christoph
Trauma Surgery Department, Alfried Krupp Hospital, Alfried-Krupp-Str. 21, 45131, Essen, Germany.
Department of Trauma and Hand Surgery, University Hospital, Duesseldorf, Germany.
BMC Emerg Med. 2019 Jan 23;19(1):13. doi: 10.1186/s12873-019-0221-x.
Whether enhanced prehospital volume therapy leads to outcome improvements in severely injured patients with severe traumatic brain injury (TBI) remains controversial. The aim of this study was to investigate the influence of prehospital volume therapy on the clinical course of severely injured patients with severe TBI.
Data for 122,672 patients from TraumaRegister DGU (TR-DGU) was analyzed. Inclusion criteria were defined as follows: Injury Severety Score (ISS) ≥ 16, primary admission, age ≥ 16 years, Abbreviated Injury Scale (AIS) head ≥3, administration of at least one unit of packed red blood cells (pRBCs), and available volume and blood pressure data. Stratification based on the following matched-pair criteria was performed: group 1: prehospital volumes of 0-1000 ml; group 2: prehospital volumes of ≥1501 ml; AIS head (3, 4, 5 + 6 and higher than for other body regions); age (16-54, 55-69, ≥ 70 years); gender; prehospital intubation (yes/no); emergency treatment time +/- 30 min.; rescue resources (rescue helicopter, emergency ambulance); blood pressure (20-60, 61-90, ≥ 91 mmHg); year of accident (2002-2005, 2006-2009, 2010-2012); AIS thorax, abdomen, and extremities plus pelvis.
A total of 169 patients per group fulfilled the inclusion criteria. Increasing volume administration was associated with reduced coagulation capability and reduced hemoglobin (Hb) levels (prothrombin ratio: group 1: 68%, group 2: 63.7%; p ≤ 0.04; Hb: group 1: 11.2 mg/dl, group 2: 10.2 mg/dl; p ≤ 0.001). It was not possible to show a significant reduction in the mortality rate with increasing volumes (group 1: 45.6, group 2: 45.6; p = 1).
The data presented in this study demonstrates that prehospital volume administration of more than 1500 ml does not improve severely injured patients with severe traumatic brain injury (TBI).
院前强化容量治疗是否能改善重度创伤性脑损伤(TBI)重伤患者的预后仍存在争议。本研究旨在探讨院前容量治疗对重度TBI重伤患者临床病程的影响。
分析了来自创伤注册数据库DGU(TR-DGU)的122672例患者的数据。纳入标准定义如下:损伤严重程度评分(ISS)≥16,初次入院,年龄≥16岁,简明损伤定级标准(AIS)头部损伤评分≥3,至少输注1单位浓缩红细胞(pRBCs),以及有可用的容量和血压数据。根据以下匹配对标准进行分层:第1组:院前容量为0 - 1000毫升;第2组:院前容量≥1501毫升;AIS头部损伤评分(3、4、5 + 6以及高于身体其他部位);年龄(16 - 54岁、55 - 69岁、≥70岁);性别;院前插管(是/否);急诊治疗时间±30分钟;救援资源(救援直升机、急救救护车);血压(20 - 60 mmHg、61 - 90 mmHg、≥91 mmHg);事故年份(2002 - 2005年、2006 - 2009年、2010 - 2012年);AIS胸部、腹部、四肢及骨盆损伤评分。
每组共有169例患者符合纳入标准。增加容量输注与凝血能力降低和血红蛋白(Hb)水平降低相关(凝血酶原比率:第1组:68%,第2组:63.7%;p≤0.04;Hb:第1组:11.2 mg/dl,第2组:10.2 mg/dl;p≤0.001)。随着容量增加,未显示死亡率有显著降低(第1组:45.6%,第2组:45.6%;p = 1)。
本研究呈现的数据表明,院前输注超过1500毫升的容量并不能改善重度创伤性脑损伤(TBI)重伤患者的状况。